GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Eutilex Co Ltd (XKRX:263050) » Definitions » Common Stock

Eutilex Co (XKRX:263050) Common Stock : ₩18,399 Mil (As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Eutilex Co Common Stock?

Eutilex Co's quarterly common stock increased from Mar. 2024 (₩18,381 Mil) to Jun. 2024 (₩18,399 Mil) but then stayed the same from Jun. 2024 (₩18,399 Mil) to Sep. 2024 (₩18,399 Mil).

Eutilex Co's annual common stock increased from Dec. 2021 (₩7,740 Mil) to Dec. 2022 (₩18,381 Mil) but then stayed the same from Dec. 2022 (₩18,381 Mil) to Dec. 2023 (₩18,381 Mil).


Eutilex Co Common Stock Historical Data

The historical data trend for Eutilex Co's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eutilex Co Common Stock Chart

Eutilex Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Common Stock
Get a 7-Day Free Trial Premium Member Only 3,652.63 7,529.23 7,739.74 18,381.43 18,381.43

Eutilex Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18,381.43 18,381.43 18,381.43 18,399.43 18,399.43

Eutilex Co Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Eutilex Co Business Description

Traded in Other Exchanges
N/A
Address
Daeryung Technotown 17, Suite 1401, Gasan Digital 1-ro 25, Geumcheon-gu, Seoul, KOR, 08594
Eutilex Co Ltd is a Korean that operates in the anti-tumor immunotherapy market. The company develops anti-tumor T cell therapy and antibody therapeutics based on its immunotherapy technology. Its pipeline products include T Cell Therapy (4-1BB CTL), CAR-T, and Antibody.

Eutilex Co Headlines

No Headlines